NORTHERN TRUST CORP - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 91 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,998,093
-22.7%
1,068,499
+3.7%
0.00%
Q2 2023$2,585,405
+2117.2%
1,030,042
+1445.8%
0.00%
Q1 2023$116,608
-45.7%
66,633
+32.0%
0.00%
Q4 2022$214,600
+694.8%
50,494
+120.5%
0.00%
Q3 2022$27,000
-93.7%
22,903
-87.0%
0.00%
Q1 2022$431,000
-16.8%
175,682
-8.9%
0.00%
Q4 2021$518,000
-46.7%
192,802
-0.7%
0.00%
Q3 2021$972,000
+279.7%
194,066
+466.5%
0.00%
Q2 2021$256,00034,2550.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Polar Capital Holdings Plc 5,800,000$27,260,0000.16%
Inscription Capital, LLC 17,000$80,0000.03%
ExodusPoint Capital Management, LP 185,844$873,0000.01%
HoyleCohen, LLC 10,359$49,0000.01%
Virtu Financial LLC 10,835$51,0000.01%
Tower Research Capital LLC (TRC) 3,783$18,0000.00%
Renaissance Technologies 253,212$1,190,0000.00%
Baillie Gifford 372,261$1,749,0000.00%
CAPSTONE INVESTMENT ADVISORS, LLC 37,238$175,0000.00%
BREWIN DOLPHIN LTD 1,970$9,2590.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders